PTC-299-HEM-001-LEU: Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias

April 01, 2019
https://clinicaltrials.gov/ct2/show/NCT03761069
Cancer - Leukemia
Principal Investigator: Ahmad H Mattour, MD
Relapsed, Refractory, Acute, Leukemia
Accepting Participants